Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Mol Cell Cardiol ; 138: 256-268, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31866376

RESUMO

Vascular calcification (VC) is a major cause of mortality in patients with chronic kidney disease (CKD). While elevations in serum phosphorus contribute to VC, we provide evidence here for a major role of oxidative stress (OS) in VC pathogenesis without an apparent increase in serum phosphorus in early CKD. In a rat model for stage 5 CKD (CKD5), we observed 1) robust increases of VC and OS, 2) significant reductions of smooth muscle 22 alpha (SM22α) and calponin, and 3) upregulations in Runt-related transcription factor 2 (RUNX2) and collagen I in vascular smooth muscle cells (VSMCs). Inhibition of OS using MnTMPyP dramatically reduced these events without normalization of hyperphosphatemia. In CKD5 patients with VC (n = 11) but not in those without VC (n = 13), OS was significantly elevated. While the serum levels of calcium and phosphate were not altered in the animal model for early stage CKD (ECKD), OS, VC, SM22α, calponin, RUNX2, collagen I and NADPH oxidase 1 (NOX1) in VSMCs were all significantly changed. More importantly, serum (5%) derived from patients with ECKD (n = 30) or CKD5 (n = 30) induced SM22α and calponin downregulation, and RUNX2, collagen I, NOX1 upregulation along with a robust elevation of OS and calcium deposition in primary rat VSMCs. These alterations were all reduced by MnTMPyP, ML171 (a NOX1 inhibitor), and U0126 (an inhibitor of Erk signaling). Collectively, we provide a comprehensive set of evidence supporting an important role of OS in promoting VC development in CKD patients (particularly in those with ECKD); this was at least in part through induction of osteoblastic transition in VSMCs which may involve the Erk singling. Our research thus suggests that reductions in OS may prevent VC in CKD patients.


Assuntos
Estresse Oxidativo , Insuficiência Renal Crônica/complicações , Calcificação Vascular/etiologia , Calcificação Vascular/patologia , Animais , Cálcio/sangue , Células Cultivadas , Humanos , Sistema de Sinalização das MAP Quinases , Masculino , Músculo Liso Vascular/patologia , Miócitos de Músculo Liso/patologia , Osteoblastos/metabolismo , Osteoblastos/patologia , Fosfatos/sangue , Ratos Sprague-Dawley , Diálise Renal , Insuficiência Renal Crônica/sangue , Calcificação Vascular/sangue
2.
Cell Signal ; 51: 139-151, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-30081092

RESUMO

Renal interstitial fibrosis is a common renal injury resulted from a variety of chronic kidney conditions and an array of factors. We report here that Notch3 is a potential contributor. In comparison to 6 healthy individuals, a robust elevation of Notch3 expression was observed in the renal tubular epithelial cells of 18 patients with obstructive nephropathy. In a rat unilateral ureteral obstruction (UUO) model which mimics the human disease, Notch3 upregulation closely followed the course of renal injury, renal fibrosis, TGFß expression, and alpha-smooth muscle actin (α-SMA) expression, suggesting a role of Notch3 in promoting tubulointerstitial fibrosis. This possibility was supported by the observation that TGFß, the major renal fibrogenic cytokine, stimulated Notch3 expression in human proximal tubule epithelial HK-2 cells. TGFß enhanced the activation of ERK, p38, but not JNK MAP kinases in HK-2 cells. While inhibition of p38 activation using SB203580 did not affect TGFß-induced Notch3 expression, inhibition of ERK activation with a MEK1 inhibitor PD98059 dramatically reduced the event. Furthermore, enforced ERK activation through overexpression of the constitutively active MEK1 mutant MEK1Q56P upregulated Notch3 expression in HK-2 cells, and PD98059 reduced ERK activation and Notch3 expression in HK-2 cells expressing MEK1Q56P. Collectively, we provide the first clinical evidence for Notch3 upregulation in patients with obstructive nephropathy; the upregulation is likely mediated through the TGFß-ERK pathway. This study suggests that Notch3 upregulation contributes to renal injury caused by obstructive nephropathy, which could be prevented or delayed through ERK inhibition.


Assuntos
Células Epiteliais/metabolismo , Nefropatias/metabolismo , Túbulos Renais Proximais/metabolismo , Sistema de Sinalização das MAP Quinases/fisiologia , Receptor Notch3/metabolismo , Fator de Crescimento Transformador beta/fisiologia , Obstrução Ureteral/metabolismo , Adulto , Animais , Células Cultivadas , Doença Crônica , Modelos Animais de Doenças , Células Epiteliais/citologia , Feminino , Fibrose/metabolismo , Regulação da Expressão Gênica , Humanos , Nefropatias/patologia , Túbulos Renais Proximais/citologia , Masculino , Pessoa de Meia-Idade , Ratos , Ratos Sprague-Dawley , Obstrução Ureteral/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...